The frequency of IFNγ+ CD4+ T cells and Th1 cells was significantly decreased after treatment for arthritis-irAE, whereas the frequency of IL-17+ CD4+ T cells, t-Th17 cells, and Th17 cells was unchanged after treatment (Fig. 6b). This evidence concerns the gene IFNG and arthritic joint disease.